CCM
BSX icon

Catapult Capital Management’s Boston Scientific BSX Stock Holding History

Catapult Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$5.5M Buy
335,000
+185,000
+123% +$3.16M 2.08% 9
2015
Q2 		$2.65M Buy
+150,000
New +$2.68M 0.38% 88

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LTI
Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Catapult Capital Management's BSX Position: Q3 2015 in Review

Catapult Capital Management increased its Boston Scientific (BSX) stake by 123% in Q3 2015, buying an estimated $3.16M and bringing the position to 335,000 shares worth $5.5M. The position accounts for 2.08% of the portfolio, ranked #9.

Catapult Capital Management first reported a position in BSX in Q2 2015 and has held it in 2 quarters since. 481 funds tracked by Wall St. Rank hold BSX as of Q3 2015.

  • Catapult Capital Management held 335,000 shares of Boston Scientific worth $5.5M as of Q3 2015.
  • Catapult Capital Management bought 185,000 Boston Scientific shares in Q3 2015, an estimated $3.16M.
  • Boston Scientific made up 2.08% of Catapult Capital Management's portfolio in Q3 2015, its #9 holding.
  • Catapult Capital Management first reported a position in Boston Scientific in Q2 2015 and has held it in 2 quarters since.
  • 481 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2015.

Based on Catapult Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.